Clinical Outcomes of Ruxolitinib in the Salvage Treatment of Chronic Graft-Versus-Host Disease

被引：0
|
作者：
Ji, Yanping [1 ]
Tang, Baolin [2 ]
Zhu, Xiaoyu [2 ]
Liu, Huilan [2 ]
Song, Kaidi [2 ]
Wan, Xiang [2 ]
Yao, Wen [2 ]
Sun, Guangyu [2 ]
Wang, Jian [3 ]
Sun, Zimin [2 ]
机构：
[1] Anhui Med Univ, Anhui Prov Hosp, Hefei, Peoples R China
[2] Univ Sci & Technol China, Affiliated Hosp 1, Div Life Sci & Med, Hefei, Peoples R China
[3] Univ Sci & Technol China, Anhui Prov Hosp, Hefei, Peoples R China
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-130138
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5677
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Ruxolitinib as Salvage Therapy for Chronic Graft-versus-Host Disease
    Modi, Badri
    Hernandez-Henderson, Michael
    Yang, Dongyun
    Klein, Jeremy
    Dadwal, Sanjeet
    Kopp, Erin
    Huelsman, Karen
    Mokhtari, Sally
    Ali, Haris
    Al Malki, Monzr M.
    Spielberger, Ricardo
    Salhotra, Amandeep
    Parker, Pablo
    Forman, Stephen
    Nakamura, Ryotaro
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (02) : 265 - 269
  • [2] Ruxolitinib for Chronic Graft-versus-Host Disease
    Shibusawa, Motoharu
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (17): : 1631 - 1631
  • [3] Ruxolitinib for treatment of Graft-versus-Host Disease
    Krueger, W. H.
    Neumann, T.
    Weigel, M.
    Plis, A.
    Schneidewind, L.
    Vaizian, R.
    Schmidt, C. A.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 70 - 71
  • [4] Ruxolitinib for the treatment of graft-versus-host disease
    Ali, Haris
    Salhotra, Amandeep
    Modi, Badri
    Nakamura, Ryotaro
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (04) : 347 - 359
  • [5] Efficiency and Toxicity of Ruxolitinib as a Salvage Treatment for Steroid-Refractory Chronic Graft-Versus-Host Disease
    Wang, Dong
    Liu, Yin
    Lai, Xiaoxuan
    Chen, Jia
    Cheng, Qiao
    Ma, Xiao
    Lin, Zhihong
    Wu, Depei
    Xu, Yang
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [6] Ruxolitinib for Chronic Graft-versus-Host Disease REPLY
    Zeiser, Robert
    Teshima, Takanori
    Locatelli, Franco
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (17): : 1632 - 1632
  • [7] Belumosudil and ruxolitinib combination for treatment of refractory chronic graft-versus-host disease
    Pusic, Iskra
    Lee, Catherine
    Veeraputhiran, Muthu
    Minor, Chelsea
    Dipersio, John F.
    BONE MARROW TRANSPLANTATION, 2024, 59 (02) : 282 - 284
  • [8] Ruxolitinib for the treatment of steroid refractory pediatric chronic graft-versus-host disease
    Belina, Morgan E.
    Driscoll, Timothy A.
    Blanchard, Sarah K.
    Cardones, Adela R.
    PEDIATRIC DERMATOLOGY, 2022, 39 (03) : 432 - 433
  • [9] Belumosudil and ruxolitinib combination for treatment of refractory chronic graft-versus-host disease
    Iskra Pusic
    Catherine Lee
    Muthu Veeraputhiran
    Chelsea Minor
    John F. DiPersio
    Bone Marrow Transplantation, 2024, 59 : 282 - 284
  • [10] Efficacy and safety of ruxolitinib in the treatment of chronic graft-versus-host disease: a retrospective analysis
    Denk, Alexander
    Mittermaier, Cornelia
    Weber, Daniela
    Fante, Matthias
    Gunes, Sibel
    Edinger, Matthias
    Herr, Wolfgang
    Wolff, Daniel
    ANNALS OF HEMATOLOGY, 2024, 103 (09) : 3755 - 3764
12345